Prevention of Parent-to-Child Transmission
| Countries and their respective targets |
| Bangladesh None |
| Cambodia Percentage HIV exposed infants who receive a HIV test within 12 months of birth: 70% Percentage HIV exposed infants who start CTX prophylaxis within 2 months of birth: 70% |
| China Percentage HIV exposed infants who receive a HIV test within 18 months of birth: 80% Percentage infants born to HIV-positive women who receive formula feeding: 90% |
| India 80% HIV-positive pregnant women will be reached by PPTCT services (2012) 90% of HIV-exposed infants will receive co-trimoxazole prophylaxis and have access to EID (2012) |
| Indonesia None |
| Lao PDR Percentage of infants born to identified HIV positive mothers receive ARV prophylaxis for PPTCT: 100% |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea Percent of HIV-positive children receiving ART: 80% |
| Thailand Percentage infants born to HIV-positive mothers who receive formula feeding (2011): 100% |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia Provision of lifelong ART for pregnant women with HIV who require treatment (2015): 100% |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh Percentage pregnant women with HIV receive ARV prophylaxis for PPTCT: 80% |
| Cambodia Percentage HIV-positive pregnant women who receive ARVs for PPTCT 75% |
| China Percentage HIV-positive pregnant women who receive ARVs for PPTCT: 90% Percentage of HIV-exposed infants who receive ARV for PPTCT: 90% |
| India None |
| Indonesia None |
| Lao PDR Percentage identified pregnant women with HIV receive ARV prophylaxis for PPTCT: 90% |
| Malaysia None |
| Myanmar Number of HIV-positive pregnant women who received ARVs to reduce the risk of PTCT: 2,680 |
| Nepal By 2011 - Proportion of HIV-positive pregnant women who receive ARVs to reduce the risk of PTCT: 80% |
| Papua New Guinea Percent of HIV positive pregnant women receiving PPTCT services: 80% |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh None |
| Cambodia Percentage Pregnant women tested for HIV and receive their results: 85% |
| China Percentage Pregnant women tested for HIV, Syphilis, and HBV: 80% |
| India None |
| Indonesia None |
| Lao PDR Percentage pregnant women receive HIV counselling and testing: 70% |
| Malaysia Percentage pregnant women tested and receive HIV test results (2010): 70% Participation of private clinics in antenatal HIV screening (2012): 80% Participation of private clinics in antenatal HIV screening (2015): 100% |
| Myanmar Percentage pregnant women who are HIV infected (Primary prevention of HIV): 0.67% |
| Nepal None |
| Papua New Guinea Percent of pregnant women receiving HIV counseling and testing services: 80% |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Read 5667 times
Published in
Prevention of Parent-to-Child Transmission
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
| Countries and their respective targets |
| Bangladesh None |
| Cambodia Percentage male partners who were tested for HIV and received their results: 40% |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand Reduction in new HIV infections among couples (2016): 75% Percentage pregnant women whose male partner received HIV testing (2011): 50% |
| Vietnam None |
|
Framework Indicators measured:
|
| A key feature of the elimination initiative is its focus on improving the health and survival of women and children in the context of HIV/STIs. This target underscores that PPTCT interventions do not end at delivery, and emphasizes the importance of linking HIV-infected children with lifesaving care and treatment. | |||
| MEASURE OF TARGET | NUMERATOR | DENOMINATOR | METHOD OF MEASUREMENT |
| Percentage of HIV-infected children (aged 0-14 years) who are currently receiving ART (UA Indicator) |
Number of children who are receiving antiretroviral therapy in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period |
Number of women Estimated number of children with advanced HIV infection | Numerator: National programme records drawn from data collected in ART registers at facilities Denominator: Estimated by the method recommended by the UNAIDS/WHO Reference Group on Estimates, Modelling and Projections using Spectrum software |
| ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 8 | |||||
| No. | Indicator | What does it measure | Numerator | Denominator | Method of Measurement |
| 18 | % of infants born to HIV-infected women receiving a virological test for HIV within 2 months of birth (UA Indicator) |
The extent to which infants born to HIV-infected women are tested within the first 2 months of life to determine their HIV status, disaggregated by test results |
Number of infants who received an HIV test within 2 months of birth, during the reporting period, disaggregated by test results Including positive, negative, indeterminate, and rejected for testing by the laboratory. Infants tested should only be counted once. The numerator should only include the most recent test result for an infant tested in the first 2 months of life, and not any earlier tests. | Estimated number of HIV-infected pregnant women giving birth in the last 12 months |
Numerator: Collected from databases held at Early Infant Diagnosis testing laboratories Denominator: Projection model such as Spectrum*
|
| 20 | Percentage of HIV-exposed infants who are receiving exclusive breastfeeding, replacement feeding or mixed feeding at DPT3 visit (Infants will be aged around 3 months) (UA Indicator) |
Feeding of HIV-exposed infants, derived from 24-h recall, measured at the time of the third dose of diphtheria, pertussis and tetanus vaccine (DPT3) | The numerators capture feeding practices only for known HIV-exposed infants who visit a health facility at or around DPT3 visit, and are disaggregated as follows: 10a: Number exclusively breastfeeding 10b: Number receiving replacement feeding 10c: Number receiving mixed feeding |
The number of HIV-exposed infants whose feeding practice has been assessed at DPT3 visit. |
Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers Denominator: Total number of exposed infants whose feeding was assessed. |
| 21 | Percentage of infants born to HIV- infected women who are started on co-trimoxazole prophylaxis within 2 months of birth (UA Indicator) |
The provision and coverage of co-trimoxazole prophylaxis for HIV-exposed infants in line with international guidelines | Number of infants born to HIV-infected women started on co-trimoxazole prophylaxis within 2 months of birth in the past 12 months | Estimated number of HIV-infected pregnant women who gave birth in the past 12 months |
Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers Denominator: Projection model such as Spectrum* |
* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.